Test date
2026-03-01
Purity
99.90%
99.9%
Batch / lot
SBM9SF7
Lab
Finnrick
Quantity
—
Qty vs label
—
Endotoxins
—
Test score
—
Manufacturer
Allen Biotechnology Co Abc
Source
abc_telegram
⚠ Asserted only
No verifiable evidence captured.
This entry was added to our corpus from abc_telegram.
We did not save the certificate image, did not hash an artifact,
and the upstream URL is either
a domain root or absent — we cannot independently confirm this report existed. Treat
as curator-asserted only.
- Dose
- 30mg
- Catalogued
- 2026-05-26
OCR text
Raw extracted text
OCR text
Raw extracted text
Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display.
FINNRICK Finnrick Testing Certificate Test Certificate ID: sbm9sf7 Verify at https://finnrick.com/verify Page 1 of 2 BT Labs Report #: IF-824-QSA-TR006-2026-115-92 Page 1 of 2 Title: Certificate of Analysis (CoA) Date: 3/4/2026 Date Tested: 3/1/2026 Customer: Finnrick Testing material: Tirzepatide Lot Number: SBM9SF7 BT Sample ID: 005000039009629 Labeled Peptide Content/Potency: 30 mg Storage: R.T. Visual Description: small clear vial: white sample, white label, silver crimp, orange plastic cap. Labeled as: Tirzepatide Manufacturer: n/a Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins. Test Method Specification Result General [NAME_REDACTED] USP <630> white powder white powder Mass USP <41> As recorded 80.9 mg FTIR Identification and Composition Analysis USP <197A> Sample spectrum should confirm the content of peptide via characteristic bands FTIR sample spectrum confirms the presence of Tirzepatide with addition of excipient(s)/fillers. HPLC Purity of Peptide Assay USP <621> Specifications: ≥ 98 % 99.9 % [NAME_REDACTED] USP <621> Specifications: 90 - 110% of 30 mg 35.4 mg (118 %) Peptide-to-Excipients Ratio USP <1151> Recommended ratios of (1:2) to (1:10) for (peptide: excipients) 35.4 : 45.5 mg (1:1.3) The results of the CoA relate only to the item(s) tested and applied to the sample as received. [NAME_REDACTED], AS Digitally signed by [NAME_REDACTED], AS DN: CN=BTLabs, OU=BioTools Inc., E=[EMAIL_REDACTED] Reason: I am the author of this document Location: Date: 2026.03.05 16:30:17 -05'00' Foxit PDF Reader Version: 2025.1.0 [NAME_REDACTED], AS Digitally signed by [NAME_REDACTED], AS' DN: CN=[NAME_REDACTED], AS', E=[EMAIL_REDACTED] Reason: I am the author of this document Location: Date: 2026.03.05 16:30:17 -05'00' Foxit PDF Reader Version: 2025.1.0 [NAME_REDACTED], AS Scientist-I BTLabs [NAME_REDACTED], AS Scientist-I BTLabs [ADDRESS_REDACTED] | Suite 220 | West Palm Beach, FL 33407 Phone: [PHONE_REDACTED] E-mail: [EMAIL_REDACTED] | Website: https://btlabtesting.com Finnrick Testing Certificate © 2026 Finnrick Analytics LLC and its suppliers, all rights reserved. Unauthorized distribution and modification prohibited. IF-824-QSA-TR006-2026-115-92 Rev 1.0 January 2025
This COA is part of TitrateLab's community-trust corpus.
See more from Allen Biotechnology Co Abc
or learn how trust scores are computed on the
methodology page.